Next Article in Journal
Xestospongia muta Fraction-7 and Linoleic Acid: Effects on SR-BI Gene Expression and HDL Cholesterol Uptake
Next Article in Special Issue
Barbamide Displays Affinity for Membrane-Bound Receptors and Impacts Store-Operated Calcium Entry in Mouse Sensory Neurons
Previous Article in Journal
Marine-Derived Actinomycetes: Biodegradation of Plastics and Formation of PHA Bioplastics—A Circular Bioeconomy Approach
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Cosmetic Application of Cyanobacteria Extracts with a Sustainable Vision to Skincare: Role in the Antioxidant and Antiaging Process

1
CIIMAR/CIMAR—Interdisciplinary Centre of Marine and Environmental Research, University of Porto, Terminal de Cruzeiros do Porto de Leixões, Av. General Norton de Matos s/n, 4450-208 Matosinhos, Portugal
2
FCUP—Faculty of Sciences, University of Porto, Rua do Campo Alegre, Edifício FC4, 4169-007 Porto, Portugal
3
Health and Environment Research Centre, School of Health, Polytechnic Institute of Porto, Rua Dr. António Bernardino de Almeida, 400, 4200-072 Porto, Portugal
*
Author to whom correspondence should be addressed.
Mar. Drugs 2022, 20(12), 761; https://doi.org/10.3390/md20120761
Submission received: 7 November 2022 / Revised: 29 November 2022 / Accepted: 29 November 2022 / Published: 2 December 2022
(This article belongs to the Special Issue Bioactive Product from Marine Cyanobacteria)

Abstract

:
Nature-based and sustainably sourced cosmetics have been dominating the area of skincare products worldwide. Due to their antioxidant and antiaging properties, compounds from cyanobacteria, such as carotenoids and phycobiliproteins, may replace synthetic ingredients in cosmetic formulations and may be used in products such as sunscreens, skincare creams, and makeup. In this study, we evaluated the potential of acetonic and aqueous extracts from cyanobacteria strains of the genera Cyanobium and Leptothoe and from strains within Synechococcales and Oscillatoriales orders, for use in cosmetics. Extractions were sequentially performed with acetone and water. Extracts were firstly analyzed for their toxicity to keratinocytes, fibroblasts, and endothelial cells (HaCAT, 3T3L1 and hCMEC/D3, respectively). The non-cytotoxic extracts were characterized in terms of total proteins, carotenoids, chlorophyll, phenols, phycobiliproteins, and analyzed for their antioxidant potential against the superoxide anion radical (O2•−), and for their ability to inhibit key enzymes associated with the skin aging process. Aqueous extracts were richer in total proteins and phycobiliproteins. The aqueous extracts of Synechococcales cyanobacterium LEGE 181157 and Synechococcales cyanobacterium LEGE 181150 showed the highest value for total proteins (760.81 and 695.25 μg BSA mL−1dry extract, respectively) and the best values regarding O2•− scavenging (IC50 = 63.24 and 112.18 μg mL−1dry extract, respectively) with a significant negative correlation observed (p < 0.01). Moreover, aqueous extracts of Synechococcales cyanobacterium LEGE 181150 and Synechococcales cyanobacterium LEGE 181157 inhibited hyaluronidase, (IC50 of 483.86 and 645.06 μg mL−1dry extract, respectively), with a significant negative correlation with total proteins (p < 0.05), pointing out the contribution of these compounds to the biological activities observed. Acetonic extracts were richer in carotenoids and phenols. Zeaxanthin and β-carotene were predominant among all strains, being present in higher amount in Cyanobium sp. LEGE 07175 (53.08 μg mg−1) and Leptothoe sp. LEGE 181156 (47.89 μg mg−1), respectively. The same strains also showed the highest values for collagenase inhibition at 750 μg mL−1dry extract (32.88 and 36.61%, respectively). Furthermore, Leptothoe sp. LEGE 181156 exhibited the lowest IC50 value for tyrosinase inhibition (465.92 μg mL−1dry extract) and Synechococcales cyanobacterium LEGE 181157 presented the best values for elastase inhibition (IC50 of 380.50 and IC25 of 51.43 μg mL−1dry extract). In general, cyanobacteria extracts demonstrated potential for being used for antiaging purposes, with aqueous extracts being more efficient at free radicals scavenging and acetonic ones at avoiding degradation of dermal matrix components.

1. Introduction

Thriving cosmetics properties include skin protection against chemical and physical factors such as xenobiotics, ultraviolet radiation (UVR), and dehydration, the main factors involved in skin’s loss of integrity and aging. Despite being a result of natural physiological features, the skin aging process may be accelerated by mechanisms such as oxidative stress, which settles down with the accumulation of free radicals. Oxidative stress is mainly responsible for triggering the activation of matrix metalloproteinases (MMPs), namely collagenases, elastases, and hyaluronidases, that contribute to the degradation of collagen, elastin, and hyaluronic acid (HA), as the main components of the extracellular matrix (ECM), which are essential for the maintenance of skin elasticity, firmness, and regeneration [1]. Consequently, the aesthetic appearance of the skin becomes compromised, which affects health, social well-being, and self-esteem. Thus, skincare habits have become a priority among people who seek a healthier and more pleasing lifestyle.
Cosmetic ingredients derived from photosynthetic organisms are a beneficial approach to prioritize the use of natural raw materials into final products that respect the skin’s properties and the environment and, consequently, make a commitment to sustainability [2]. Among photosynthetic organisms, the interest in cyanobacteria has been growing, with different species being explored from the natural cosmetics point of view. Cyanobacteria are widespread organisms found in all ecosystems, some with life-threatening conditions such as high temperatures, high salinity, and extreme solar radiation [3]. As extremely adaptable organisms, cyanobacteria have developed a remarkable secondary metabolism, resulting in an arsenal of metabolites with proven pharmaceutical, nutraceutical, and food-conservation potential. Considering skin-related needs, the production of carotenoids, phenolic compounds, phycobiliproteins (PBPs), mycosporin-like amino acids (MAAs), and scytonemin (SCY) places these organisms at the forefront of healthy skincare. All these molecules play a central role as antiaging ingredients, mainly due to their antioxidant potential, sun-protection capacity, and ability to inhibit enzymes responsible for the degradation of the ECM [2,4].
The use of cyanobacteria-derived compounds in skincare products can be expressed in sunscreens, moisturizing creams, formulations with antioxidant and anti-inflammatory properties, as well as in pigmentation disorders, dermatophytosis, and infectious diseases [1,2,5,6,7]. Recent studies focusing on the potential of cyanobacteria in cosmetics have reported the antioxidant activity attributed to the production of carotenoids from some genera, namely Leptolyngbya, Synechocystis, and Wollea [2,8], PBP such as phycocyanin (PC) and phycoerythrin (PE) from Arthrospira sp. and Spirulina sp. [8,9], and phenolic compounds from Nostoc commune [10]. Considering the inhibition of MMPs compounds such as mycosporin-2-glycine isolated from a halotolerant cyanobacterium was found to inhibit collagenase activity [11], cyclodepsipeptide from Schizothrix sp. and Coleofasciculus sp. presented high elastase inhibitory properties [12], and a polyssacharide from Nostochopsis lobatus showed potent hyaluronidase inhibitory activity [13]. Additionally, Favas and co-workers recently showed that some cyanobacteria aqueous extracts had the potential to retard dermal density loss [14]. Additionally, the extract from Phormidium persicinum (PHORMISKIN Bioprotech G®) has been commercially used as a melanin synthesis reducer [15]. The studies involving cyanobacteria as photoprotectors have also been highlighted [16]. It is known that cyanobacteria synthetize pigments, which are UVR-absorbing compounds, namely carotenoids, PBPs, MAAs, and SCY [16]. The available literature produced so far highlights the biotechnological potential of cyanobacteria as natural and eco-friendly sources of compounds in the field of skincare and triggers further exploitation in this field. Besides being self-renewable, with low nutritional requirements, and presenting high growth and photosynthesis rates, the sustainable cultivation of cyanobacteria is guaranteed [2,17].
In the present work, seven cyanobacteria strains isolated from Portuguese and Cape Verde marine ecosystems (Cyanobium sp. LEGE 07175, Synechococcales cyanobacterium LEGE 181150, Leptothoe sp. LEGE 181155, Leptothoe sp. LEGE 181156, Synechococcales cyanobacterium LEGE 181157, Synechococcales cyanobacterium LEGE 181158, and Oscillatoriales cyanobacterium LEGE 181159) were explored for their potential to slow down skin aging. Acetonic and aqueous extracts were evaluated for cytotoxicity in skin cell-lines, phytochemical composition, antioxidant potential, and inhibitory effect in skin key enzymes.

2. Results

2.1. Cytotoxicity

Cytotoxic effects were registered in all cell lines for both acetonic and aqueous extracts of the strain Leptothoe sp. LEGE 181155 (g and n in Figures S1–S3) and for the acetonic extract of strain Oscillatoriales cyanobacterium LEGE 181159 (m in Figures S1–S3), with a significant decrease from the lowest concentration (12.5 μg mL−1) (p < 0.05) after 24 h For all other strains, none of the extracts showed cytotoxic effects, with no significant differences from the control (p < 0.05) for both 24 and 48 h of exposition. Based on these results, the extracts of the strain Leptothoe sp. LEGE 181155 and the acetone extract of Oscillatoriales cyanobacterium LEGE 181159 were excluded from the study (Results and Supplementary Material).

2.2. Phytochemical Analysis

For the purpose of comparing the chemical profiles and establishing a relationship between the chemical composition and the biological activities assessed herein, the acetonic and aqueous extracts were characterized in terms of phenolic content, total proteins, and PBP. Moreover, the qualitative and quantitative carotenoids profile was also established.

2.2.1. Carotenoids

The HPLC-PDA analysis of the acetonic extract from the different cyanobacteria strains allowed the detection of 13 carotenoids, 2 chlorophyll-a derivatives, and chlorophyll-a, and for the aqueous extract 8 carotenoids, 2 chlorophyll-a derivatives and chlorophyll-a (Table 1). The chromatographic profile of the three different genera is illustrated in Figure 1.
The identified compounds for aqueous extracts consisted of two xanthophylls: zeaxanthin (5) and myxoxanthophyll (7); one carotene: β-carotene (13), chlorophyll-a (4) and the chlorophyll-a derivative phaeophytin-a (14). For acetonic extracts, the identified compounds consisted of four xanthophylls: lutein (2), zeaxanthin (5), myxoxanthophyll (7) and echinenone (10); two carotenes: β-carotene (13) and γ-carotene (16), as well as chlorophyll-a (4) and phaeophytin-a (14). Seven compounds with the same spectra as the identified carotenoids, however, with different retention times to the standard, were also detected in some strains, being defined as unidentified carotenoids (1, 3, 8, 9, 11, 12, 15), and the same was carried out for the chlorophyll-a derivative (6). Regarding aqueous extracts, five compounds were defined as unidentified carotenoids (1, 3, 9, 12, 15).
For aqueous extracts, total carotenoid concentration ranged between 0.05 and 3.00 μg mg−1 of dry extract. Cyanobium sp. LEGE 07175 showed the highest carotenoids content, followed by Synechococcales cyanobacterium LEGE 181150 and Oscillatoriales cyanobacterium LEGE 181159 (3.00; 1.55 and 0.84 μg mg−1, respectively) (p < 0.05). All strains contain β-carotene (13), Zeaxanthin (5), and phaeophytin-a (14), but in Cyanobium sp. LEGE 07175, this chlorophyll-a derivative could not be quantified. Myxoxanthophyll (7) was not found in two of six strains. Lutein (2) and γ-carotene (16) were not identified in any aqueous extract.
According to chlorophylls, the total chlorophylls content ranged from 0.81 up to 14.77 μg mg−1. Chlorophyll-a (4) was found in all strains, except in Cyanobium sp. LEGE 07175, where only a chlorophyll-a derivative (6) was found. The highest chlorophylls content was found in Synechococcales cyanobacterium LEGE 181150 (14.77 μg mg−1) (p < 0.05), followed by Synechococcales cyanobacterium LEGE 181158 and Oscillatoriales cyanobacterium LEGE 181159 (9.42 and 8.69 μg mg−1), with no significant differences.
Regarding acetonic extract, the total carotenoid concentration ranged between 104.71 and 150.15 μg mg−1 of dry extract, and it differed significantly. The highest carotenoids content was found in Leptothoe sp. LEGE 181156 followed by Synechococcales cyanobacterium LEGE 181150 and Cyanobium sp. LEGE 07175 (150.15; 123.26; and 115.98 μg mg−1, respectively) (p < 0.05). Lutein (2) was found in two strains: Synechococcales cyanobacterium LEGE 181157 and Synechococcales cyanobacterium LEGE 181158. Zeaxanthin (5) was identified in all strains, but in Synechococcales cyanobacterium LEGE 181150 and Synechococcales cyanobacterium LEGE 181158, this xanthophyll appeared co-eluted with chlorophyll-a (4). The highest content of this xanthophyll was found in Cyanobium sp. LEGE 07175 (53.08 μg mg−1) (p < 0.05). Even though Cyanobium sp. LEGE 07175 was the only one that did not present myxoxanthophyll (7), it was the only strain in which echinenone (10) was identified. All the other strains presented β-carotene (13), phaeophytin-a (14), and γ-carotene (16) in their profile. The highest content of β-carotene was found in the strain Leptothoe sp. LEGE 181156 (47.89 μg mg−1) (p < 0.05) followed by Synechococcales cyanobacterium LEGE 181158 and Synechococcales cyanobacterium LEGE 181157 (30.57 and 29.30 μg mg−1, respectively). The highest phaeophytin-a content was detected in Synechococcales cyanobacterium LEGE 181158, followed by Cyanobium sp. LEGE 07175 and Synechococcales cyanobacterium LEGE 181157 (6.31; 5.81; and 5.23 μg mg−1, respectively) with no significant differences (Table 1 and Figure 1).
Regarding chlorophylls, the total chlorophylls content ranged from 12.69 up to 34.81 μg mg−1. Chlorophyll-a (4) derivative was identified in all strains of acetonic extracts in considerably high amounts when compared with chlorophyll-a. Synechoccocales cyanobacterium LEGE 181156 presented the highest content, followed by Synechococcales cyanobacterium LEGE 181150 and Synechococcales cyanobacterium LEGE 181158 (34.81; 29.23 and 21.90 μg mg−1, respectively) with no significant differences. Additionally, in two strains, namely Synechococcales cyanobacterium LEGE 181150 and Synechococcales cyanobacterium LEGE 181158, chlorophyll-a (4) was also present; however, it was co-eluted with zeaxanthin (5). Amongst the pigments analyzed, carotenoids were dominant over chlorophylls in all strains for acetonic extraction. Furthermore, zeaxanthin, phaeophytin-a, and γ-carotene were identified in the acetonic extracts of all the species studied (Figure 1, Table 1).
Acetonic extracts were richer in pigments than aqueous extracts, considering both carotenoids and chlorophylls. The unique carotenoid identified for all strains, in both extractions, was β-carotene. Moreover, the carotene echinenone was only identified in Cyanobium sp. LEGE 07175.

2.2.2. Total Phenolic Content (TPC)

For both extracts, TPC was measured through the Folin–Ciocalteu colorimetric assay; the results were expressed in μg of GAEs per mg of dry extract and are displayed in Table 2.
Acetonic extracts presented higher TPC values than aqueous extracts. The highest TPC was found in the acetonic extract of Leptothoe sp. LEGE 181156, followed by Synechococcales cyanobacterium LEGE 181158 and Cyanobium sp. LEGE 07175 (27.13; 24.71; and 23.11 μg GAE mg−1dry extract, respectively) with not significant differences.
Regarding aqueous extracts, the values ranged from 11.46 up to 15.67 μg GAE mg−1dry extract, Synechococcales cyanobacterium LEGE 181158 being the strain with the highest TPC, with no significant differences among the samples, except between Oscillatoriales cyanobacterium LEGE 181159, which showed lower content, and Synechococcales cyanobacterium LEGE 181158 (Table 2).

2.2.3. Total Proteins

The total protein content of both extracts was evaluated by the method of BSA, using the protein assay kit, and the results were expressed in μg of BSA per mg of dry extract (Table 2). Higher values were found in the aqueous extraction, in which Synechococcales cyanobacterium LEGE 181157 presented the highest content, followed by Synechococcales cyanobacterium LEGE 181150 and Synechococcales cyanobacterium LEGE 181158 (760.81; 695.25 and 579.99 μg BSA mg−1dry extract, respectively) (p < 0.05).
Regarding acetonic extracts, Synechococcales cyanobacterium LEGE 181158 showed the highest content, followed by Synechococcales cyanobacterium LEGE 181150 (209.31 and 199.37 μg BSA mg−1dry extract, respectively) with no significant difference.

2.2.4. Phycobiliproteins (PBPs)

As water-soluble proteins, PBPs were quantified only in aqueous extracts. Regarding PC, the Synechococcales cyanobacterium LEGE 181150 extract presented the highest content, followed by Oscillatoriales cyanobacterium LEGE 181159 and Synechococcales cyanobacterium LEGE 181158 (222.76; 201.15; and 194.43 μg mg−1dry extract, respectively) (p < 0.05). In contrast, Synechococcales cyanobacterium LEGE 181157 possessed the highest content of PE, followed by Leptothoe sp. LEGE 181156 and Oscillatoriales cyanobacterium LEGE 181159 (275.04; 159.05 and 26.33 μg mg−1dry extract, respectively) (p < 0.05) (Table 3).
The strong blue color of PC was notable is the aqueous extracts of Synechococcales cyanobacterium LEGE 181150, Oscillatoriales cyanobacterium LEGE 181159, and Synechococcales cyanobacterium LEGE 181158; and the strong pink/red color of PE was observed in the aqueous extracts of Synechococcales cyanobacterium LEGE 181157 and Leptothoe sp. LEGE 181156, which is in accordance with the main phycobiliproteins quantified in each strain.

2.3. Biological Activities

Superoxide Anion Radical (O2•−) Scavenging
The results of O2•− scavening capacity of both cyanobacteria extracts are summarized in Table 4 and Figure 2. Aqueous extracts were more effective and presented lower IC50 values than acetonic extracts towards radical scavenging. Synechococcales cyanobacterium LEGE 181157 was the most effective strain, showing the lowest IC50 value (63.24 μg mL−1dry extract), followed by Synechococcales cyanobacterium LEGE 181150 (112.18 μg mL−1dry extract), with no significant difference, and Oscillatoriales cyanobacterium LEGE 181159 (332.40 μg mL−1dry extract) (p < 0.05).
Concerning acetonic extracts, the lowest IC50 was presented by Synechococcales cyanobacterium LEGE 181157, followed by Synechococcales cyanobacterium LEGE 181150 and Leptothoe sp. LEGE 181156 (847.65; 943.45; and 1097.05 μg mL−1dry extract) with no significant differences among the species (Table 4).

2.4. Enzymes Inhibition

2.4.1. Hyaluronidase (Hase) Inhibition

For both extracts studied herein, the strains of the order Synechoccales presented higher potential for Hase inhibition. Synechococcales cyanobacterium LEGE 181150 showed the lowest IC50 value for aqueous and acetonic extracts (483.86 and 726.29 μg mL−1dry extract, respectively), followed by Synechococcales cyanobacterium LEGE 181158 (624.51 and 738.88 μg mL−1dry extract, respectively) and Synechococcales cyanobacterium LEGE 181157 (645.06 and 859.83 μg mL−1dry extract, respectively), with no significant differences between them. Leptothoe sp. LEGE 181156 was the unique strain for which the acetonic extracts did not reach IC50 nor IC25 values (Table 5).

2.4.2. Elastase Inhibition

For elastase, only the acetonic extracts showed inhibitory potential, with Synechococcales cyanobacterium LEGE 181157 being the only strain that reached IC50, with a value of 380.50 μg mL−1dry extract. Regarding IC25, this strain reached an interesting value (51.43 μg mL−1dry extract) (p < 0.05), followed by Synechococcales cyanobacterium LEGE 181158 and Leptothoe sp. LEGE 181156 (233.47 and 378.26 μg mL−1dry extract) (Table 5).

2.4.3. Tyrosinase Inhibition

As for elastase, only acetonic extracts were able to promote tyrosinase inhibition (Table 5). Leptothoe sp. LEGE 181156 reached IC50, followed by Synechococcales cyanobacterium LEGE 181157 (465.92 and 849.48 mg mL−1, respectively) (p < 0.05). Additionally, both were also able to reach IC25 with values of 133.47 and 381.33 mg mL−1, respectively) with no significant differences.

2.4.4. Collagenase Inhibition

Contrary to the previous enzymes, the IC values were not able to be determined for collagenase. Due to the scarce amount of enzyme available, we chose to carry out the assay in kinetic mode, using the result of the calculation by slope of the linear equation line. In this sense, the inhibitory activity of the extracts was tested at two different concentrations of 0.75 and 1 mg mL−1.
Acetonic extracts were more effective than aqueous ones towards collagenase inhibition (Table 6). Leptothoe sp. LEGE 181156 presented 36.61% of collagenase inhibition for the tested concentration of 0.75 mg mL−1, while Cyanobium sp. LEGE 07175 reached 32.88% for the same concentration. Although Synechococcales cyanobacterium LEGE 181150 showed 9.81% of collagenase inhibition at 0.75 mg mL−1, this strain presented 44.40% when tested at 1.0 mg mL−1.
Regarding aqueous extracts, Synechococcales cyanobacterium LEGE 181158 was the most effective strain against collagenase, presenting 25.97% of inhibition at 1.0 mg mL−1.

3. Discussion

The stratified squamous epithelium that constitutes the epidermis is mainly composed of keratinocytes and corneocytes and is in a constant process of cell renewal. In the dermis, fibroblasts are essential cells involved in the production and maintenance of the collagen and elastic fibers that ensure resistance and the elasticity of the skin. In addition, dermis is richly vascularized, being responsible for the nutrition and oxygenation of the epidermis [1].The absence of cytotoxicity to main skin cells, both from the epidermis and dermis, is mandatory in a skin formulation. In this work, although seven strains were initially selected, the strain Leptothoe sp. LEGE 181155 was excluded due to the cytotoxic effects of both extracts on keratinocytes, fibroblasts, and endothelial cells. Additionally, due to cytotoxic effects in all cell lines tested, the acetone extract of Oscillatoriales cyanobacterium LEGE 181159 was also excluded. Thus, only nontoxic extracts were further analyzed.

3.1. Phytochemical Analysis

3.1.1. Carotenoids and Chlorophylls

Among the studied strains, the acetonic extract of the strain Leptothoe sp. LEGE 181156 was the richest in carotenoids (150.15 μg mg−1 dry extract) (p < 0.05). The highest concentration of carotenoids in aqueous extracts was obtained with strain Cyanobium sp. LEGE 07175 with a maximum of 3.00 μg mL−1 dry extract. As expected, the results obtained indicated that acetone extraction is more efficient than the aqueous on both carotenoids and chlorophylls (Table 1), which can be explained by the lower polar nature of these compounds, and therefore a higher affinity for lower polar solvents such as acetone. Additionally, as extractions were carried out in sequential mode, in which the acetonic extraction was performed first, most of these pigments were extracted with acetone.
Considering carotenoids identification, the xanthophyll zeaxanthin was found in all acetonic extracts of all species studied, ranging from 24.38 to 53.08 μg mg−1dry extract, with the highest value reported in Cyanobium sp. LEGE 07175, followed by Leptothoe sp. LEGE 181156 (53.08 and 39.85 µg mg−1 dry extract, respectively) (p < 0.05). In a previous study by Morone and co-workers [18], a 70% ethanolic extract by Cyanobium sp. LEGE 07175 exhibited 16.31 μg g−1 of dry biomass, with the best value being presented by Synechocystis salina LEGE 06099, with 49.82 μg g−1 of dry biomass. In this work, in terms of dry biomass, acetonic extracts of Cyanobium sp. LEGE 07175 presented a value of 799 μg g−1 and Leptothoe sp. LEGE 181156 a value of 498 μg g−1. Zeaxanthin’s properties include photoprotection in cyanobacteria and reduction of oxidative damage in humans’ eyes [19,20].
Myxoxanthophyll was detected in all cyanobacteria acetonic extracts and most aqueous extracts, except for Cyanobium sp. LEGE 07175. In contrast, echinenone was only detected in Cyanobium sp. LEGE 07175 with a concentration of 1.17 μg mg−1dry extract. This same carotenoid was detected in a 70% ethanol extract of Cyanobium gracile LEGE 12431 (7.31 μg mg−1dry extract) [21]. Echinenone was also found in other genera of cyanobacteria [18,21]. According to previous studies, this carotenoid is important in cyanobacteria photoprotection [19].
Beta-carotene is a terpene of relevant importance due to its important role as an antioxidant. This carotenoid was found in all strains in both acetone and aqueous extracts. For acetonic extracts, the concentrations ranged from 19.58 to 47.89 μg mg−1dry extract. There was a significant difference among the strain Leptothoe sp. LEGE 181156 and the Synechococcales, strains LEGE 181158, LEGE 181157, and LEGE 181150, which did not differ significantly from each other. These results may corroborate a study that analyzed the patterns of carotenoid synthesis in different genera and concluded that strains of the same genus present the same patterns of pigments production, namely concerning β-carotene [22]. Previous studies also reported β-carotene in different genera of cyanobacteria, namely, Synechocystis, Nodosilinea, Phormidium, Leptolyngybya-like, Cuspidothrix, Anabaena, Nostoc, Aphanothece, and Gloeothece [18,21,23,24,25], which validates the broad spectrum of cyanobacterial genera that produce this compound, and thus its importance in industries such as cosmetics.
Morone et al., 2020 [18], showed that a 70% ethanol extract of Cyanobium sp. LEGE 07175 presented 8.06 μg of β-carotene per g of dry biomass. Accounting the extraction yield, in the present work, the acetonic extract of Cyanobium sp. LEGE 07175, which exhibited 19.58 μg mg−1dry extract, presented a value of 295 μg g−1 in terms of dry biomass. Another example is Leptothoe sp. LEGE 181156, which exhibited the highest value for β-carotene (47.89 μg mg−1dry extract) and, in terms of dry biomass, showed a value of 599 μg g−1, for acetonic extract.
As β-carotene, γ-carotene was also detected in the acetonic extract of all species studied, although below the limit of quantification in Cyanobium sp. LEGE 07175. In addition to the antioxidant potential, β-carotene and γ-carotene are precursors of retinol, which works as a storage form of vitamin A and can be transformed into other modes of activation, such as retinoic acid and retinal [26]. In skin, retinoids are widely used in the treatment of diseases such as cancer, psoriasis, acne, ichthyosis, and even wrinkles due to their effect on cell differentiation, proliferation, and apoptosis [27]. Therefore, β-carotene and γ-carotene are two interesting carotenoids to be explored in cosmetics [28].
In this study, we found that zeaxanthin, β-carotene, and γ-carotene were the main carotenoids detected in most of the samples analyzed. A relevant aspect in the production of carotenoids in cyanobacteria is that by changing the culture conditions, it is possible to increase the production of these compounds. A previous study involving the optimization of culture conditions for cyanobacteria revealed that high light radiation may increase the production of carotenoids, such as β-carotene, echinenone, and myxoxanthophyll, and may exhibit strong protection under photo-oxidative conditions [29]. The results from the present study indicated that, despite the low yield achieved with the acetonic extraction (around 1.5 to 2% per gram of dry biomass (Table 7), the amount of carotenoids extracted with acetone may be profitable when compared to water, which presented percentages at least 20 times higher.
Amongst the pigments analyzed herein, the total chlorophylls content, including chlorophyll-a and its derivatives, was lower than total carotenoids, except for aqueous extracts. Unlike the results of our study, Lopes et al., 2020 [21], showed that chlorophylls were dominant over carotenoids in both, ethanol and acetonic extractions; however, the strains evaluated by the author were of terrestrial origin, which may explain the differences. Chlorophylls, as well as carotenoids, act as antioxidants and are widely used in the food, cosmetic, and pharmaceutical industries [30].

3.1.2. Total Phenolic Content (TPC)

Despite the limitations inherent to colorimetric assays, the determination of TPC by the Folin–Ciocalteu method is widely used to determine total phenols in plant extracts, as well as to infer about their antioxidant potential. Overall, acetonic extracts had higher phenolic content than aqueous ones. Although phenolic compounds are soluble in solvents with higher polarity, the fact that the extraction was carried out sequentially with acetone and water led to the extraction of most of the compounds with acetone. The highest TPC was found in the acetone extract of Leptothoe sp. LEGE 181156, with 27.13 μg GAE mg−1 dry extract with no significant differences when compared to Synechococcales cyanobacterium LEGE 181158 and Cyanobium sp. LEGE 07175 (24.71 and 23.11 μg GAE mg−1 dry extract, respectively). In a previous study by Morone et al. [18], using a 70% ethanol extract, Cyanobium sp. LEGE 07175 had a value of 1.09 mg GAE g−1dry biomass, which was higher than the result obtained herein for the same strain (0.29 mg GAE g−1, converted according to extraction yield). Another study with the same genus [31], revealed values around 82 μg GAE mg−1dry extract for acetonic extracts of another Cyanobium sp. Favas et al. [14], presented a value of 17.59 μg GAE mg−1dry extract for acetonic extract of Leptolyngbya cf. ectocarpi LEGE 11479.
Regarding aqueous extracts, although the values are lower, between 14.49 to 15.67 μg GAE mg−1dry extract, when converted to dry biomass, the results turn out to be promising, considering the excellent yield that aqueous extraction may provide; for example, this was true for Synechococcales cyanobacterium LEGE 181150 and Synechococcales cyanobacterium LEGE 181157, which were the strains that presented the best results (6.48 and 4.33 mg GAE g−1dry biomass, respectively). However, regarding acetonic extracts, the results were much lower for the same strains in terms of dry biomass (0.39 and 0.30 mg GAE g−1dry biomass, respectively). Phenolic compounds are known for their beneficial effect against humans, including skin diseases, namely due to their anti-inflammatory and antioxidant potential [32]. In the skin, phenolic compounds were found to be active as antioxidants and anti-inflammatories [33] and are effective at inhibiting the enzyme tyrosinase, and thus at treating aesthetic problems such as hyperpigmentation [34]. Regarding marine cyanobacteria, as far as we are aware, there are no other previous reports on the TPC, corroborating the importance of further exploitation of cyanobacteria extracts concerning antioxidant activity.

3.1.3. Proteins

Proteins play a key role in the structure and integrity of the skin. The main benefit of using proteins in cosmeceuticals is related to improving skin hydration, as they act as water-binding molecules. In addition to being responsible for forming collagen, which is a protein that gives firmness to skin and prevents the formation and exacerbation of wrinkles and expression lines, proteins are the main basis for the formation of new tissues, also being implicated in improving wound healing. Furthermore, proteins present UV protection capacity, antimicrobial, and antioxidant properties. Therefore, there is a growing search for products with antiaging action based on bioactive peptides [35]. In this study, the characterization of the total protein content of the extracts studied was carried out. It was confirmed that the aqueous extracts presented much higher values than the acetonic ones, with emphasis on strains used in this work within the order Synechococcales, which showed promising results. Synechococcales cyanobacterium LEGE 181157 ranked first with 760.81 μg (BSA) mg−1dry extract (p < 0.05), followed by Synechococcales cyanobacterium LEGE 181150 (p < 0.05) and Synechococcales cyanobacterium LEGE 181158 (695.25 and 579.99 μg (BSA) mg−1dry extract, respectively). Converting to extraction yield, the values are 220, 331, and 100 mg (BSA) g−1dry biomass, respectively. Therefore, in terms of biomass, Synechococcales cyanobacterium LEGE 181150 exhibited the highest value. Favas and coworkers, 2022 [14] also reported higher values for aqueous extracts than acetonic ones, in which the freshwater strain Cephlothrix lacustris LEGE 15493 presented 521.18 μg (BSA) mg−1dry extract.

3.1.4. Phycobiliproteins (PBPs)

Phycobiliproteins are water-soluble proteins, which are deep-colored, formed by a complex between proteins and covalently bound phycobilins. Phycocyanin (PC), allophycocyanin (APC), and phycoerythrin (PE) are the three main PBPs groups, absorbing light within specific regions of the spectrum, according to their structure and types of bilins [9]. In recent years, the demand for microorganisms to synthetize natural colorants for cosmetics has increased in order to replace synthetic ones used in lipsticks, eyeliners, and blushes [2]. The PBPs PC, of blue color; APC, blue-green; and PE and PEC, both of red/pink color, have been already used as a natural coloring in foods, nutritional supplements, cosmetics, and as fluorescent markers in immunoassays [36].
As water-soluble compounds, PBPs were only analyzed in aqueous extracts. As visually confirmed through its intense pink color, the aqueous extract of the strain Synechococcales cyanobacterium LEGE 181157 was the richest in PE (275.04 μg mg−1 dry extract) followed by the strain Leptothoe sp. LEGE 181156 (159.05 μg mg−1 dry extract) (p < 0.05). Validated by the strong blue color, Synechococcales cyanobacterium LEGE 181150 aqueous extract was the richest in PC (222.76 μg mg−1 dry extract) (p < 0.05). Regarding APC, Oscillatoriales cyanobacterium LEGE 181159 presented the highest value, followed by Synechococcales cyanobacterium LEGE 181150 (65.90 and 57.29 μg mg−1 dry extract, respectively). Only Cyanobium sp. LEGE 07175, with a light green extract, showed significantly lower values. In terms of dry biomass, Synechococcales cyanobacterium LEGE 181157 exhibited 113.18 mg g−1 dry biomass for PE and Synechococcales cyanobacterium LEGE 181150 83.53 mg g−1 dry biomass for PC. These values are in accordance with literature data, namely for PE concentration in the thermotolerant cyanobacterium Leptolyngbya sp. KC45 (100 mg g−1) [37]. For PC, the value described is within the concentrations obtained with different strains of Spirulina, as exposed in a recent review by Jaeschke and co-workers [38] in which different methods of PC extraction from Spirulina strains are compared. Concerning total PBPs by dry biomass, the results obtained are also in accordance with reported data for the strain Synechococcales cyanobacterium LEGE 181157 (179 mg g−1dry biomass) compared with in the strain Anabaena sp. NCCU-9 (91 mg g−1dry biomass) [39] and Cyanobium sp. (200 mg g−1dry biomass) [31]. The results obtained confirm the use of cyanobacteria to obtain natural dyes and expand the range of genera with this potential. Along with the coloring role, PBPs are described as potent antioxidant and anti-inflammatory agents, properties that are beneficial in cosmetic formulations [40].

3.1.5. Antioxidant Potential

In this work, the relevant physiological free radical O2•−, one of the major ROS that provoke oxidative damage in the human body, was used to determine the antioxidant potential of cyanobacteria extracts. In terms of radical scavenging, the aqueous extract of the strain Synechococcales cyanobacterium LEGE 181157 was the most effective, presenting the best IC50 value of 63.24 μg mL−1dry extract, followed by Synechococcales cyanobacterium LEGE 181150 (112.18 μg mL−1dry extract) (p > 0.05). Synechococcales cyanobacterium LEGE 181157 was also the strain that presented the highest value for total proteins (760.81 μg BSA mg−1dry extract) (p < 0.05), followed by Synechococcales cyanobacterium LEGE 181150, with 695.25 μg BSA mg−1dry extract. Moreover, Synechococcales cyanobacterium LEGE 181157 showed the highest value for PE (275.04 μg mg−1dry extract) (p < 0.05), and Synechococcales cyanobacterium LEGE 181150 presented the highest content for PC (222.76 μg mg−1dry extract) (p < 0.05). According to the statistical analyses, a significant negative correlation was found between the total proteins and the IC values (−0.982, p < 0.01 for IC50 and −0.739, p < 0.01 for IC25). In addition, a negative correlation was also observed between PE and IC values, and the same occurred for the TPC. Furthermore, a significant negative correlation was found between ICs and PC (−0.680, p < 0.05 and −0.749, p < 0.01, for IC50 and IC25, respectively). Although Leptothoe sp. LEGE 181156 was the only strain that did not reach the IC50 for aqueous extract, this strain managed to obtain more than 40% of enzymatic inhibition at the concentration 104.00 μg mL−1dry extract, and its IC25 reached 41.10 μg mL−1extract dry (Figure 2). This antioxidant activity observed in the aqueous extracts may be attributed to their richness in proteins and PBP.
Regarding the acetonic extracts, strains belonging to Synechococcales cyanobacterium order, followed by Leptothoe sp. LEGE 181156, showed the best results for free-radical sequestration (p > 0.05). However, the values were much higher than those displayed by the aqueous extract. These acetonic extracts are richer in carotenoids than aqueous extracts (Table 1). According to the statistical analyses, although they lacked statistical significance, negative correlations were noted with total carotenoids content, lutein, β-carotene, and γ-carotene. Favas et al. [14], using both extractions, also reported a higher effectiveness for the aqueous extracts when compared to the acetonic ones. In their work, aqueous extracts of Cephalothrix lacustris LEGE 15493 showed an IC50 of 65.50 μg mL−1dry extract, while the IC50 of its acetonic extract was not detected. Morone et al. [18], who studied ethanol extracts of other species, reported the lowest IC50 value for Phormidium sp. LEGE 05292 (822.70 μg mL−1). Amaro and co-workers [23] revealed that Scenedesmus obliquus (M2-1) showed an IC50 of 826 μg mL−1 for acetonic extract. According to the studies published so far, aqueous extracts have shown great potential in terms of their ability to scavenge O2•−. In this way, we may consider the interest of the aqueous extracts of the strains explored in our work for cosmeceutical applications.

3.1.6. Inhibition of Metalloproteinases (MMPs)

The dermis ECM is extremely important for the maintenance of skin structure. When collagen, elastin, and HA are degraded or deficient, the effects are expressed in the visual appearance of the skin. Under oxidative stress, an inflammatory response with activation of MMPs such as collagenase, elastase, and HAase is triggered, contributing to the degradation of these ECM vital components, and promoting wrinkles formation [1,41]. Tyrosinase is another enzyme that is also activated mainly by external factors, such as exposure to UV rays. This enzyme acts in photoprotection as a catalyst in the synthesis of melanin, but when overactivated, it causes pigmentation lesions, such as vitiligo, or hyperpigmentation marks, such as melasma and age spots [42]. Triggered by the importance of MMPs inhibitors in skin, the ability of the aqueous and acetonic extracts to inhibit these key enzymes was explored.
Regarding HAase, the lowest results for IC50 were presented by the aqueous extracts of the species belonging to the order Synechococcales, in which the strain Synechococcales cyanobacterium LEGE 181150 presented the best value (483.86 μg mL−1dry extract). For acetonic extracts, the results were around 750 μg mL−1dry extract. Regarding statistical analysis, there is a strong negative correlation between total proteins and the IC50 for both aqueous and acetonic extracts (−0.593, p < 0.05 and −1.000 p < 0.01, respectively) and a negative correlation between TPC and IC50, also for both extracts, suggesting that both proteins and phenols may be implicated in the inhibition of this enzyme. Synechococcales cyanobacterium LEGE 181150 was the strain exhibiting one of the highest total proteins for both extractions, which corroborates the deductions above. In this study, the value of total proteins for aqueous extracts of Cyanobium sp. was not as high as that presented by the strains belonging to Synechococcales order, which is also in line with the statistical correlations found. Our results highlight the importance of aqueous extracts as potential antiaging ingredients, possibly due to their protein content. Although the aqueous extract of Cyanobium sp. LEGE 07175 displayed an IC50 of 894.59 μg mL−1, in a previous study realized by us [18], a 70% ethanol extract of this strain, Cyanobium sp. LEGE 07175, showed stronger inhibitory activity (IC50 = 208.36 μg mL−1). This may be due to a synergistic effect between the compounds extracted by ethanol 70%, since this solvent has more affinity to a mixture of polar and less polar compounds, contrary to water, from which compounds of more polar nature are mainly extracted. Furthermore, Pagels et al. [43], showed considerable IC50 for aqueous and acetonic extracts, using another strain of the genus Cyanobium (67.25 and 108.74 μg mL−1, respectively). Favas et al. [14], presented the lowest value for aqueous extract of Leptolyngbya cf. ectocarpi LEGE 11479 (863 μg mL−1dry extract) and only IC25 for acetonic extracts. A previous work focusing polysaccharides from cyanobacteria [13] reported that Nostochopsis lobatus MAC0804NAN had a notable IC50 of 7.18 μg mL−1 for HAase inhibition. These results caught our interest since, considering the polar nature of polysaccharides, these compounds may also be present in the aqueous extracts and, together with proteins, contribute to the inhibition of the enzyme.
Inhibition of elastase was only achieved with acetonic extracts, Synechococcales cyanobacterium LEGE 181157 being the unique one that reached IC50 value (380.50 μg mL−1dry extract. In addition, its IC25 presented an interesting value of 51.43 μg mL−1dry extract. On the other hand, this strain was not able to inhibit collagenase. For acetonic extracts, collagenase inhibition was achieved at 750 μg mL−1 for Leptothoe sp. LEGE 181156 and Cyanobium sp. LEGE 07175 (36.61 and 32.88%, respectively), and at 1000 μg mL−1 for Synechococcales cyanobacterium LEGE 181150, with 44.40%. Favas et al. [14], reported that acetonic extracts of Leptolyngybya cf. ectocarpi LEGE 11479 reached IC50 (391 μg mL−1dry extract) for elastase inhibition, and Pagels et al. [43] showed collagenase inhibition for aqueous extract of the strain Cyanobium sp. LEGE 06113 (IC50 = 582.82 μg mL−1) but with no results below 1000 μg mL−1 for elastase and tyrosinase inhibition. Regarding aqueous extracts, Synechococcales cyanobacterium LEGE 181158 presented 25.97% of inhibition at 1000 μg mL−1. As presented above, this strain also exhibited inhibition of hyaluronidase.
Finally, IC50 for tyrosinase was displayed for the acetonic extracts for two strains. Leptothoe sp. LEGE 181156 was the only strain that exhibited IC results for both tyrosinase (IC50 = 465.92 μg mL−1 and IC25 =133.47 μg mL−1) and elastase (IC25 = 378.26 μg mL−1). In addition, this strain also showed collagenase inhibition of 36.61% at a concentration of 750 μg mL−1dry extract. With respect to Synechococcales cyanobacterium LEGE 181157, ICs values for hyaluronidase, elastase and tyrosinase inhibition were found, the IC25 being more attractive (613.47, 51.43, and 381.33 μg mL−1dry extract, respectively). A more detailed analysis showed a significant negative correlation between TPC (−0.972, p < 0.05), Total Proteins (−0.984, p < 0.05) and Total Carotenoids (−0.974, p < 0.05), and IC50. Additionally, zeaxanthin, β-carotene (−0.956, p < 0.05), and γ-carotene showed a negative correlation in relation to tyrosinase inhibition. For the same enzyme, Favas et al. [14], reported that only the acetonic extract of Nodosilinea nodulosa LEGE 06104 was able to reach IC50 (989.26 μg mL−1dry extract). Ethanol extracts studied by Morone et al. [18] did not show tyrosinase inhibition.
In a general way, extracts richer in proteins seem to be more effective for free radicals scavenging, being more attractive to counteract oxidative stress, while acetonic extracts, which are richer in carotenoids and phenols, seem more effective as enzyme inhibitors. Regarding phenolic compounds, it seems that they contribute to both biological activities evaluated.

4. Materials and Methods

4.1. Cyanobacteria Strains and Biomass Production

Seven cyanobacterial strains isolated from the Portuguese and Cape Verde marine ecosystems and maintained in the Blue Biotechnology and Ecotoxicology Culture Collection (LEGE-CC) at the Interdisciplinary Centre of Marine and Environmental Research (CIIMAR) [44] were randomly chosen for this study, with the aim of conducting a more comprehensive screening of the most promising cyanobacteria strains. The strains panel included the picoplanktonic Cyanobium sp. LEGE 07175 from Portuguese marine ecosystem and the filamentous Synechococcales cyanobacterium LEGE 181150 [45], Leptothoe sp. LEGE 181155, Leptothoe sp. LEGE 181156, Synechococcales cyanobacterium LEGE 181157, Synechococcales cyanobacterium LEGE 181158, and Oscillatoriales cyanobacterium LEGE 181159, from Cape Verde marine ecosystems, which are in the process of publication. For biomass production, a scale-up culture scheme up to 4 L was set. The strains were grown in Z8 medium [46], supplemented with 10 µg/L vitamin B12 and 25 g/L of synthetic sea salts (Tropic marin, Berlin, Germany). Cultures were maintained at 25 °C, with a light intensity of 10–30 μmol photons m−2 s−1 and with a photoperiod of 14h light:10h dark. The fresh biomass was collected by filtration, frozen, freeze-dried, and stored at −20 °C until extracts preparation.

4.2. Extract Preparation

Acetone and aqueous extracts were sequentially prepared from each strain by following the procedure described by Favas et al. [14]. First, the acetonic extract was prepared using 2 g of dry biomass. The biomass was suspended in 80 mL of acetone and extracted for 10 min in an ultrasonic bath (Fisherbrand®-FB15053, Loughborough, UK). The supernatant was collected, and the biomass was reextracted three more times. After the acetonic extraction, the resulting pellet was left to dry in the fume hood until the remaining solvent was completely evaporated. The pellet was further extracted with 70 mL of distilled water, following the same procedure. Cell debris was removed by centrifugation (5000 Gs, 5 min, 4 °C) (Thermo ScientificTM HERAUS MegafugeTM 16R, Waltham, MA, USA). Supernatants from each extraction were evaporated under reduced pressure (acetone) (BUCHI R-210 Rotary Evaporator, Cambridge, MA, USA) or frozen and lyophilized (water). The dry extracts were kept at −20 °C until further chemical and biological analysis. The extractions yield is displayed below (Table 7).

4.3. Phytochemical Analysis

4.3.1. Determination of Pigments Profile by HPLC-PDA

Dried cyanobacteria extracts were dissolved in HPLC-grade methanol (acetonic extract) or Milli-Q water (aqueous extracts) to a final concentration of 5 and 10 mg mL−1, respectively, and filtered through a 0.2 μm pore membrane. Carotenoids analysis was performed following the method previously described [47], with slight modifications. A Waters Alliance 2695 high-performance liquid chromatography (HPLC) with photodiode array (PDA) detector (USA) was employed to resolve, detect, and identify the compounds of interest. The stationary phase was a YMC Carotenoid C30 (250 × 4.6 mm; 5 μm) column, kept at constant temperature (25 °C) with a column heater (Waters Corporation, Milford, CT, USA). The mobile phase consisted of 2 solvents: methanol (A) and tert butyl methyl ether (B) (VWR Prolabo), starting with 95% A and installing a gradient to obtain 10% B at 5 min, 18% B at 20 min, 30% B at 28 min, 50% B from 31 to 37 min, 80% B from 38 to 47 min, and 5% B from 48 to 50 min. The flow rate was 0.90 mLmin−1 and the injection volume was 5 μL. Data were processed using Empower chromatography software (Waters, USA). Spectra data from all peaks were collected in the range 250 to 750 nm.
Compounds were identified by comparing their retention times and UV-Vis spectra with those of authentic standards. Carotenoids quantification was achieved by measuring the absorbance recorded in the chromatograms relative to external standards at 450 nm.
Zeaxanthin, lutein, echinenone, myxoxanthophyll, phaeophytin-a, β-carotene, γ-carotene, and chlorophyll-a (Extrasynthese, Genay, France; Sigma-Aldrich, St. Louise, MO, USA; DHI, Horsholm, Denmark) were quantified with the authentic standards; unidentified carotenoids were quantified as zeaxanthin, the most representative xanthophyll, and chlorophyll derivatives and phaeophytin-a as chlorophyll-a, the major cyanobacteria chlorophyll. Calibration curves were performed with five different concentrations of standards, selected as representative of the range of compounds concentrations in the samples. The calibration plots and r2 values for the analyzed carotenoids and chlorophyll-a are shown in Table 8.

4.3.2. Total Phenolic Content (TPC)

The TPC of the cyanobacterial extracts was determined using the colorimetric assay of Folin–Ciocalteu, according to Barroso et al. [18,48]. The acetonic extracts were solubilized in DMSO and the aqueous extracts in water. Briefly, a volume of 25 μL of each extract (10 mg mL−1) was thoroughly mixed with 25 μL of Folin–Ciocalteu reagent (Sigma-Aldrich, St. Louis, MO, USA), 200 μL of Na2CO3 solution (75 g L−1) and 500 μL of deionized water. After the incubation period (60 min at room temperature), the absorbance of the colored product was measured at 725 nm, using a Synergy HT Multi-detection microplate reader (Biotek, Bad Friedrichshall, Germany) operated by GEN5TM software. Standard calibration curves (y = 2.097x + 0.01560, R2 = 0.9989, for aqueous extracts and y = 2.204x + 0.01401, R2 = 0.9982, for acetonic extracts) were obtained with seven concentrations of gallic acid (GA) (0.025 to 0.5 mg mL−1). TPC in each extract was expressed in µg of gallic acid equivalents (GAE) per mg of dry biomass. Three independent determinations were carried out in triplicate.

4.3.3. Total Proteins

Total proteins concentration was determined using the BSA Protein Assay kit (n° 23227, Thermo-Scientific, Waltham, MA, USA) by following the manufacturer’s instructions and according to Favas et al. [14]. Aqueous extracts were prepared in water, while acetone extracts were prepared in DMSO. Briefly, in a 96-well plate, 25µL of each extract (1 mg mL−1) was mixed with 200 µL of working reagent. The absorbance was measured at 562 nm using a Synergy HT Multi-detection microplate reader (Biotek, Bad Friedrichshall, Germany) operated by GEN5TM software. Standard curves (y = –126.87x3 + 547.73x2 + 483.85x − 10.017; R2 = 0.999 and y = 162.87x3 − 248.51x2 + 932.13x − 11.715; R2 = 0.999) were obtained for each extract (aqueous and acetonic, respectively), using nine concentrations of albumin (BSA) (25 to 2000 µg mL−1) to quantify the proteins. Three independent experiments were carried out in triplicate. The total proteins were expressed as µg of bovine serum albumin (BSA) equivalents per mg of dry extracts.

4.3.4. Phycobiliproteins

The pigments present in aqueous extracts were determined spectrophotometrically. Aqueous extracts were resuspended in water. PBPs were determined by measuring the absorbances at different wavelengths (562, 615 and 645 nm), in a cell with 1 cm of optical path. The corresponding formulas were applied, as previously described by Pagels et al. [31]:
P h y c o c y a n i n ( P C ) = A 615 n m 0.474 × A 652 n m 5.34 A l l o p h y c o c y a n i n ( A P C ) = A 652 n m 0.208 × A 615 n m 5.09 P h y c o e r y t h r i n ( P E ) = A 562 n m 2.41 × P C 0.849 × A P C 9.62
Aqueous extracts were resuspended to a final concentration of 0.5 mg mL−1. The experiment was carried out in triplicate, and the results were expressed in µg of the respective phycobiliprotein per mg of dry extract.

4.4. Cell Assays

4.4.1. Cell Culture

To assess the safety of the cyanobacteria acetonic and aqueous extracts, a preliminary in vitro cytotoxicity assay was performed using three different cell lines, the human keratinocytes HaCAT (ATCC), the mice fibroblasts 3T3L1 (ATCC) and the human endothelial cells hCMEC/D3 (provided by Dr. PO Couraud (INSERM, Paris, France). Cell culture was performed as already described by us in Morone et al. and Favas et al. Briefly, cells were cultured in DMEM Glutamax medium (Dulbecco’s Modified Eagle Medium DMEM GlutaMAXTM—Gibco, Glasgow, UK), supplemented with 10% (v/v) of fetal bovine serum (Biochrom, Berlin, Germany), 0.1% of amphotericin B (GE Healthcare, Little Chafont, UK) and 1% of Pen-Strep (penicillin-streptomycin, 100 IU mL−1 and 10 mg mL−1, respectively) (Gibco, Berlin, Germany). Cells maintenance and assays were performed in a humidified atmosphere of 5% CO2 at 37 °C. Between 80–90% cell confluence, adherent cells were washed with phosphate-buffered saline (PBS, Gibco), detached with a small amount of TrypLE Express enzyme (Gibco), passed for maintenance, and seeded for the planned assays.

4.4.2. Cytotoxicity—MTT Assay

Cytotoxicity assay was performed by measuring the reduction of 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide (MTT), as previously described [18]. Keratinocytes, fibroblasts and endothelial cells were seeded in 96-well plates at a density of 2.5 × 104 cells mL−1; 3.3 × 104 cells mL−1 and 1.0 × 105 cells mL−1, respectively. After 24 h of adhesion, the culture medium was removed and cells were exposed for 24 and 48 h to fresh medium supplemented with 1% of extracts in five serial concentrations, from 12.5 to 200 μg mL−1. Acetone extracts were prepared in dimethyl sulfoxide (DMSO, Gibco) and diluted with DMEM prior to cells exposure; the maximum DMSO concentration did not exceed 1%. DMSO at 1% and 20% were used as solvent and positive controls, respectively. Aqueous extracts were prepared in PBS and diluted with DMEM prior to cells exposition. PBS at 1% and DMSO at 20% were used as solvent and positive controls, respectively. After each incubation time, 20 μL of 1 mg mL−1 MTT (Sigma-Aldrich), was added to each well and incubated at 37 °C for 3h. Following incubation, the media were removed, and the purple-colored formazan salts were dissolved in DMSO. The absorbance was read at 550 nm in a Synergy HT Multi-detection microplate reader (Biotek, Bad Friedrichshall, Germany) operated by GEN5TM software. The assay was run in quadruplicate and averaged. Cytotoxicity was expressed as a percentage of cell viability, considering 100% viability in the solvent control. For reproducibility, each assay was independently repeated three times.

4.5. Biological Activities

4.5.1. Superoxide Anion Radical (O2•−) Scavenging

The superoxide anion radical (O2•−) scavenging activity of the extracts was determined as described previously [49] with some modifications. The acetone extracts were resuspended in DMSO, while the aqueous extracts were resuspended in water. Six serial dilutions, from 10 mg mL−1, were prepared for each extract and tested in order to evaluate the extracts’ behavior and IC values. All reagents were dissolved in phosphate buffer (19 µM, pH 7.4). A volume of 50 µL of serial dilutions of the cyanobacteria extracts (0.104 to 1.667 mg mL−1 for acetonic extracts; and 0.013 to 1.667 mg mL−1, for aqueous extracts) was mixed with 50 µL of 166 µM β-nicotinamide adenine dinucleotide reduced-form (NADH) solution and 150 µL of 43 µM nitrotetrazolium blue chloride (NBT), in a 96-well plate. A volume of 50 µL of 2.7 µM phenazine methosulphate (PMS) was added to each well. The radical scavenging activity of the samples was monitored with a Synergy HT Multi-detection Microplate Reader operated by GEN5TM (Biotek, Bad Friedrichshall, Germany), in kinetic function, at room temperature, for 2 min, at 562 nm. All reagents were dissolved in phosphate buffer (19 μM, pH 7.4). Three independent assays were performed in triplicate. GA was used as positive control. The results were expressed as a percentage of radical scavenging in comparison to the untreated control. The results for the calculated IC values were expressed as mean ± SD (µg/mL) of at least three independent assays performed in duplicate. The IC values and the corresponding dose–response curves were calculated with Graphpad Prism® software (version 9, for MacOS).

4.5.2. Hyaluronidase Inhibition

HAase Inhibition assay was determined as proposed by Ferreres et al., [50] with some modifications. The acetone extracts were resuspended in DMSO, while the aqueous extracts were resuspended in water. Six serial dilutions were prepared for each extract (0.125 to 1.0 mg mL−1 and 0.063 to 1.0 mg mL−1, respectively) and tested to evaluate the extracts’ behavior and IC values. Twenty-five microliters of each sample were added to each reaction tube. A volume of 175 µL of HA solution (0.7 mg mL−1 in water:buffer, 5:2 v/v, kept at 37 °C) was added to each reaction tube and gently mixed. The reaction started by adding 25 μL of HAase (900 U mL−1 in NaCl 0.9%). After 30 min incubation at 37 °C, the enzymatic reaction was stopped with 25 μL of disodium tetraborate 0.8 M, followed by subsequent heating for 3 min in a boiling water bath. After cooling to room temperature, 375 µL of DMBA solution was added and gently mixed (2 g of DMAB dissolved in a mixture of 2.5 mL of 10 N HCl and 17.5 mL of glacial acetic acid and further diluted 1:2 with glacial acetic acid immediately before use). The tubes were incubated at 37 °C for 20 min and the absorbance of the colored product was measured at 560 nm in a Synergy HT Multi-detection microplate reader (Biotek, Bad Friedrichshall, Germany) operated by GEN5TM software. Negative control was performed in the absence of extract. Disodium cromoglycate (DSCG) was used as positive control. Three independent assays were performed in triplicate.

4.5.3. Elastase Inhibition

Porcine pancreatic elastase inhibition assay was slightly modified from those proposed by Mota et al. [51]. Acetonic and aqueous extracts were resuspended in DMSO and water, respectively. Briefly, in a 96-well plate, 50 µL of extract (0.05 to 0.4 mg mL−1 for each extract) was mixed with 90 µL of HEPES buffer (0.1 M), 10 µL of N-succinyl-Ala-Ala-Ala p-nitroanilide substrate (100 µM), 70 µL of acetate buffer (200 mM), and 30 µL of elastase (1 U mL−1). The plate was incubated at 37 °C for 10 min, and the absorbance of the reaction product was measured at 405 nm, in a Synergy HT Multi-detection microplate reader (Biotek, Bad Friedrichshall) operated by GEN5TM. Negative control was performed in the absence of extract, and ascorbic acid was used as positive control. Three independent assays were performed in triplicate. The results were expressed as a percentage of enzyme inhibition in comparison to the untreated control.

4.5.4. Collagenase Inhibition

Collagenase inhibition assay was determined as reported by Andrade et al. [52] with some modifications. The substract N-(3-furyl-acryloyl)-Leu-Gly-Pro-Ala (FALGPA) 1 mM was dissolved in tricine buffer (50 mM, pH 7.5). Collagenase enzyme was prepared in the buffer at 1 U mL−1. First, 10 μL of extract dilutions (0.75 and 1.0 mg mL−1), 45 μL of tricine buffer, and 50 μL of collagenase (1 U mL−1) were added to a 96-well plate and kept at 37 °C for 15 min. The reaction was started by adding 120 μL of FALGPA. The substrate hydrolysis was monitored with a Synergy HT Multi-detection Microplate Reader operated by GEN5TM (Biotek, Bad Friedrichshall, Germany), operating in kinetic function, at room temperature, for 8 min, at 345 nm. Negative control was performed in the absence of extract, and gallic acid was used as positive control. Results were expressed as percentage of enzyme inhibition in comparison to the untreated control. The assay was performed in triplicate.

4.5.5. Tyrosinase Inhibition

The tyrosinase inhibition assay was performed according to Adhikari and co-workers [53], with some modifications. Five serial dilutions, from 0.063 to 1.0 mg mL−1, were prepared for each extract. Briefly, in a 96-well plate, 20 µL of each extract was mixed with 100 µL of tyrosinase (30 U mL−1 in phosphate buffer). Acetonic extracts and aqueous extracts were resuspended in DMSO and water, respectively. The mixture was incubated at 30 °C during 8 min. After that, 80 µL of L-DOPA (L-3,4-dihydroxyphenylalanine) solution (2.5 mM in phosphate buffer) was added, and the absorption was immediately read (T0) with a Synergy HT Multi-detection microplate reader (Biotek, Bad Friedrichshall, Germany) operated by GEN5TM software, at 475 nm. After 8 min, the absorbance was measured again (T8). Negative control was performed in the absence of extract, and kojic acid was used as positive control. Three independent assays were performed in triplicate. The results were expressed as a percentage of enzyme inhibition in comparison to the untreated control.

4.6. Statistical Analysis

Statistical analysis was performed using IBM SPSS STATISTICS software, version 28.0.1.0, IBM Corporation, New York, NY, USA (2021). Data were analyzed for normality and homogeneity of variances using Kolmogorov–Smirnov and Leven’s tests, and then submitted to one-way ANOVA, using a Tukey’s HSD (honest significant difference) as a post hoc test. A Pearson correlation test was used to compare normalized expression data between the chemical profile and the biological activities of cyanobacteria extracts.

5. Conclusions

Many studies have shown that, to protect themselves from the damage associated with extreme environmental conditions, such as high desiccation and UV radiation, cyanobacteria produce compounds such as carotenoids, phenolic compounds and phycobiliproteins.
This study revealed that the cyanobacteria strains evaluated stood out regarding cosmetic purposes and sustainability. The extractions were performed sequentially, allowing the obtention of different bioactive extracts from the same biomass. This increases biomass rentability, has a lower environmental impact and becomes economically attractive. The aqueous extracts of Synechococcales cyanobacterium LEGE 181157 and Synechococcales cyanobacterium LEGE 181150 strains, rich in phycobiliproteins, showed antioxidant activity, reaching an attractive IC50 for superoxide radical scavenging. Furthermore, these extracts had the ability to inhibit the enzyme HAase. As such, they seem interesting for antioxidant purposes. Moreover, PBPs, the major components of aqueous extracts, are photoprotective compounds, and their natural and attractive colors may add value in cosmetic products. On the other hand, phenols and carotenoids present in the acetonic extracts, especially in Leptothoe sp. LEGE 181156 and Synechococcales cyanobacterium LEGE 181150, demonstrated potential to preserve dermal matrix components through the inhibition of MMPs. Overall, the results obtained drive the studies on cyanobacteria towards the cosmetic industry, as a promising source of natural extracts with potential in cosmetic formulations.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/md20120761/s1, Figure S1: Keratinocyte (HaCat) viability after 24 and 48 h of incubation with cyanobacteria aqueous (a–g) and acetone (h–n) extracts. (a,h) Cyanobium sp. LEGE 07175, (b,i) Synechococcales cyanobacterium LEGE 181150, (c,j) Leptothoe sp. LEGE 181156 and (d,k) Synechococcales cyanobacterium LEGE 181157, (e,l) Synechococcales cyanobacterium LEGE 181158, (f,m) Oscillatoriales cyanobacterium LEGE 181159, (g,n) Leptothoe sp. LEGE 181155. Results are expressed as % of MTT reduction vs. the untreated control. DMSO (20%) represents the positive control. Results are expressed as mean ±SD of at least three independent assays, performed in quadruplicate. Statistical differences at * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 (One-way ANOVA; Tukey’s HSD multiple comparisons test). Figure S2: Fibroblast (3T3L1) viability after 24 and 48 h of incubation with cyanobacteria aqueous (a–g) and acetone (h–n) extracts. (a,h) Cyanobium sp. LEGE 07175, (b,i) Synechococcales cyanobacterium LEGE 181150, (c,j) Leptothoe sp. LEGE 181156 and (d,k) Synechococcales cyanobacterium LEGE 181157, (e,l) Synechococcales cyanobacterium LEGE 181158, (f,m) Oscillatoriales cyanobacterium LEGE 181159, (g,n) Leptothoe sp. LEGE 181155. Results are expressed as % of MTT reduction vs. the untreated control. DMSO (20%) represents the positive control. Results are expressed as mean ± SD of at least three independent assays, performed in quadruplicate. Statistical differences at * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 (One-way ANOVA; Tukey’s HSD multiple comparisons test). Figure S3: Endothelial cell (hCMEC/d3) viability after 24 and 48 h of incubation with cyanobacteria aqueous (a–g) and acetone (h-n) extracts. (a,h) Cyanobium sp. LEGE 07175, (b,i) Synechococcales cyanobacterium LEGE 181150, (c,j) Leptothoe sp. LEGE 181156 and (d,k) Synechococcales cyanobacterium LEGE 181157, (e,l) Synechococcales cyanobacterium LEGE 181158, (f,m) Oscillatoriales cyanobacterium LEGE 181159, (g,n) Leptothoe sp. LEGE 181155. Results are expressed as % of MTT reduction vs. the untreated control. DMSO (20%) represents the positive control. Results are expressed as mean ± SD of at least three independent assays, performed in quadruplicate. Statistical differences at * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 (One-way ANOVA, Tukey’s HSD multiple comparisons test).

Author Contributions

Conceptualization, R.M. and G.L.; methodology, J.M. (Janaina Morone), G.L., J.M. (João Morais) and J.N.; data analysis, J.M. (Janaina Morone) and G.L.; investigation, J.M. (Janaina Morone); writing—original draft preparation, J.M. (Janaina Morone); writing—review and editing, J.M. (Janaina Morone), G.L., J.M. (João Morais), J.N., R.M. and V.V.; supervision, G.L., V.V. and R.M.; funding acquisition, V.V. All authors have read and agreed to the published version of the manuscript.

Funding

This work was partially performed in the framework of the project ALGAVALOR-MicroALGAs: integrated production and valorization of biomass and its various applications-SI I&DT n.o 352234-supported by the PORTUGAL 2020 through the European Regional Development Fund; and supported by the FCT Projects UIDB/04423/2020 and UIDP/04423/2020.

Institutional Review Board Statement

Not applicable.

Data Availability Statement

Data are available upon request to the corresponding author.

Acknowledgments

Janaína Morone is grateful to Fundação para a Ciência e a Tecnologia (FCT) for the Grant nº. UI/BD/150903/2021. Graciliana Lopes thanks FCT for the financial support for her work contract through the Scientific Employment Stimulus-Individual Call (CEECIND/01768/2021). The authors acknowledge the support and the use of resources of MIRRI-ERIC, specifically of the Portuguese infrastructure node of the Microbial Resource Research Infrastructure (MIRRI-PT) NORTE-01-0145-FEDER-084445, financed by the European Regional Development Fund (ERDF) and national funds UIDB/04423/2021 and UIDP/04423/2021 through FCT/MCTES. Sampling was supported through project EMERTOX (grant 734748), funded by H2020-MSCA-RISE 2016. We also thank the Ministério da Agricultura e Ambiente de Cabo Verde under the sampling authorization of the National Environment Directorate Nº094/2019.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Morone, J.; Lopes, G.; Oliveira, B.; Vasconcelos, V.; Martins, R. Cyanobacteria in Cosmetics: A Natural Alternative for Anti-Aging Ingredients; Academic Press: Cambridge, MA, USA, 2022; pp. 257–286. [Google Scholar]
  2. Morone, J.; Alfeus, A.; Vasconcelos, V.; Martins, R. Revealing the potential of cyanobacteria in cosmetics and cosmeceuticals—New bioactive approach. Algal Res. 2019, 41, 101541. [Google Scholar] [CrossRef]
  3. Chen, L.; Li, D.; Song, L.; Hu, C.; Wang, G.; Lui, Y. Effects of Salt Stress on Carbohydrate Metabolism in Desert Soil Alga Microcoleus vaginatus Gom. J. Integr. Plant Biol. 2006, 48, 914–919. [Google Scholar] [CrossRef]
  4. Favas, R.; Morone, J.; Martins, R.; Vasconcelos, V.; Lopes, G. Cyanobacteria and microalgae bioactive compounds in skin-ageing: Potential to restore extracellular matrix filling and overcome hyperpigmentation. J. Enzym. Inhib. Med. Chem. 2021, 36, 1829–1838. [Google Scholar] [CrossRef] [PubMed]
  5. Pagels, F.; Guedes, A.; Vasconcelos, V.; Lopes, G. Anti-inflammatory compounds from cyanobacteria. In The Pharmacological Potential of Cyanobacteria; Academic Press: Cambridge, MA, USA, 2022. [Google Scholar]
  6. Assunção, J.; Amaro, H.; Malcata, F.; Guedes, A. Cyanobacterial pigments: Photosynthetic function and biotechnological purposes. In The Pharmacological Potential of Cyanobacteria; Academic Press: Cambridge, MA, USA, 2022; pp. 201–256. [Google Scholar]
  7. Singh, S.K.; Kaur, R.; Bansal, A.; Kapur, S.; Sundaram, S. Biotechnological exploitation of cyanobacteria and microalgae for bioactive compounds. In Biotechnological Production of Bioactive Compounds; Elsevier: Amsterdam, The Netherlands, 2020. [Google Scholar]
  8. Nowruzi, B.; Sarvari, G.; Blanco, S. The cosmetic application of cyanobacterial secondary metabolites. Algal Res. 2020, 49, 101959. [Google Scholar] [CrossRef]
  9. Pagels, F.; Guedes, A.C.; Amaro, H.M.; Kijjoa, A.; Vasconcelos, V. Phycobiliproteins from cyanobacteria: Chemistry and biotechnological applications. Biotechnol. Adv. 2019, 37, 422–443. [Google Scholar] [CrossRef] [PubMed]
  10. Jerez-Martel, I.; García-Poza, S.; Rodríguez-Martel, G.; Rico, M.; Afonso-Olivares, C.; Gómez-Pinchetti, J.L. Phenolic Profile and Antioxidant Activity of Crude Extracts from Microalgae and Cyanobacteria Strains. J. Food Qual. 2017, 2017, 2924508. [Google Scholar] [CrossRef] [Green Version]
  11. Tarasuntisuk, S.; Patipong, T.; Hibino, T.; Waditee-Sirisattha, R.; Kageyama, H. Inhibitory effects of mycosporine-2-glycine isolated from a halotolerant cyanobacterium on protein glycation and collagenase activity. Lett Appl. Microbiol. 2018, 67, 314–320. [Google Scholar] [CrossRef]
  12. Keller, L.; Canuto, K.M.; Liu, C.; Suzuki, B.M.; Almaliti, J.; Sikandar, A.; Naman, C.B.; Glukhov, E.; Luo, D.; Duggan, B.M.; et al. Tutuilamides A-C: Vinyl-Chloride-Containing Cyclodepsipeptides from Marine Cyanobacteria with Potent Elastase Inhibitory Properties. ACS Chem. Biol. 2020, 15, 751–757. [Google Scholar] [CrossRef]
  13. Yamaguchi, Y.; Koketsu, M. Isolation and analysis of polysaccharide showing high hyaluronidase inhibitory activity in Nostochopsis lobatus MAC0804NAN. J. Biosci. Bioeng. 2016, 121, 345–348. [Google Scholar] [CrossRef]
  14. Favas, R.; Morone, J.; Martins, R.; Vasconcelos, V.; Lopes, G. Cyanobacteria Secondary Metabolites as Biotechnological Ingredients in Natural Anti-Aging Cosmetics: Potential to Overcome Hyperpigmentation, Loss of Skin Density and UV Radiation-Deleterious Effects. Mar. Drugs 2022, 20, 183. [Google Scholar] [CrossRef]
  15. CODIF. Phormiskin Bioprotech G. Available online: https://www.codif-tn.com/en/principesactifs/phormiskin-bioprotech-g/ (accessed on 1 May 2022).
  16. Gao, X.; Jing, X.; Liu, X.; Lindblad, P. Biotechnological Production of the Sunscreen Pigment Scytonemin in Cyanobacteria: Progress and Strategy. Mar. Drugs 2021, 19, 129. [Google Scholar] [CrossRef] [PubMed]
  17. Lopes, G.; Silva, M.; Vasconcelos, V. The Pharmacological Potential of Cyanobacteria; Elsevier: Amsterdam, The Netherlands, 2022. [Google Scholar]
  18. Morone, J.; Lopes, G.; Preto, M.; Vasconcelos, V.; Martins, R. Exploitation of Filamentous and Picoplanktonic Cyanobacteria for Cosmetic Applications: Potential to Improve Skin Structure and Preserve Dermal Matrix Components. Mar. Drugs 2020, 18, 486. [Google Scholar] [CrossRef] [PubMed]
  19. Kusama, Y.; Inoue, S.; Jimbo, H.; Takaichi, S.; Sonoike, K.; Hihara, Y.; Nishiyama, Y. Zeaxanthin and Echinenone Protect the Repair of Photosystem II from Inhibition by Singlet Oxygen in Synechocystis sp. PCC 6803. Plant Cell. Physiol. 2015, 56, 906–916. [Google Scholar] [CrossRef] [PubMed]
  20. Krinsky, N.I.; Landrum, J.T.; Bone, R.A. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu. Rev. Nutr. 2003, 23, 171–201. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  21. Lopes, G.; Clarinha, D.; Vasconcelos, V. Carotenoids from Cyanobacteria: A Biotechnological Approach for the Topical Treatment of Psoriasis. Microorganisms 2020, 8, 302. [Google Scholar] [CrossRef] [Green Version]
  22. Palinska, K.A.; Deventer, B.; Hariri, K.; Łotocka, M. A taxonomic study on Phormidium-group (cyanobacteria) based on morphology, pigments, RAPD molecular markers and RFLP analysis of the 16S rRNA gene fragment. Fottea 2011, 11, 41–55. [Google Scholar] [CrossRef] [Green Version]
  23. Amaro, H.M.; Fernandes, F.; Valentao, P.; Andrade, P.B.; Sousa-Pinto, I.; Malcata, F.X.; Guedes, A.C. Effect of Solvent System on Extractability of Lipidic Components of Scenedesmus obliquus (M2-1) and Gloeothece sp. on Antioxidant Scavenging Capacity Thereof. Mar. Drugs 2015, 13, 6453–6471. [Google Scholar] [CrossRef] [Green Version]
  24. Patias, L.D.; Fernandes, A.S.; Petry, F.C.; Mercadante, A.Z.; Jacob-Lopes, E.; Zepka, L.Q. Carotenoid profile of three microalgae/cyanobacteria species with peroxyl radical scavenger capacity. Food Res. Int. 2017, 100, 260–266. [Google Scholar] [CrossRef]
  25. Hashtroudi, M.S.; Shariatmadari, Z.; Riahi, H.; Ghassempour, A. Analysis of Anabaena vaginicola and Nostoc calcicola from Northern Iran, as rich sources of major carotenoids. Food Chem. 2013, 136, 1148–1153. [Google Scholar] [CrossRef]
  26. Arnum, V.; Susan, D. Vitamin A. In Kirk-Othmer Encyclopedia of Chemical Technology; John Wiley & Sons: New York, NY, USA, 2000; pp. 99–107. [Google Scholar]
  27. Szymanski, L.; Skopek, R.; Palusinska, M.; Schenk, T.; Stengel, S.; Lewicki, S.; Kraj, L.; Kaminski, P.; Zelent, A. Retinoic Acid and Its Derivatives in Skin. Cells 2020, 9, 2660. [Google Scholar] [CrossRef]
  28. Abiri, B.; Vafa, M. Antioxidant Vitamins in Acute Lymphoblastic Leukemia, 2nd ed.; Academic Press: Cambridge, MA, USA, 2021; Chapter 48. [Google Scholar]
  29. Steiger, S.; Schafer, L.; Sandmann, G. High-light-dependent upregulation of carotenoids and their antioxidative properties in the cyanobacterium Synechocystis PCC 6803. J. Photochem. Photobiol. 1999, 52, 14–18. [Google Scholar] [CrossRef]
  30. Koller, M.; Muhr, A.; Braunegg, G. Microalgae as versatile cellular factories for valued products. Algal Res. 2014, 6, 52–63. [Google Scholar] [CrossRef]
  31. Pagels, F.; Salvaterra, D.; Amaro, H.M.; Lopes, G.; Sousa-Pinto, I.; Vasconcelos, V.; Guedes, A.C. Bioactive potential of Cyanobium sp. pigment-rich extracts. J. Appl. Phycol. 2020, 32, 3031–3040. [Google Scholar] [CrossRef]
  32. Rahman, M.M.; Rahaman, M.S.; Islam, M.R.; Rahman, F.; Mithi, F.M.; Alqahtani, T.; Almikhlafi, M.A.; Alghamdi, S.Q.; Alruwaili, A.S.; Hossain, M.S.; et al. Role of Phenolic Compounds in Human Disease: Current Knowledge and Future Prospects. Molecules 2021, 27, 233. [Google Scholar] [CrossRef]
  33. Boo, Y.C. Can Plant Phenolic Compounds Protect the Skin from Airborne Particulate Matter? Antioxidants 2019, 8, 379. [Google Scholar] [CrossRef] [Green Version]
  34. Orhan, I.E.; Khan, M.T.H. Flavonoid Derivatives as Potent Tyrosinase Inhibitors—A Survey of Recent Findings between 2008–2013. Top. Med. Chem. 2014, 14, 1486–1493. [Google Scholar] [CrossRef]
  35. Ahsan, H. Immunopharmacology and immunopathology of peptides and proteins in personal products. J. Immunoass. Immunochem. 2019, 40, 439–447. [Google Scholar] [CrossRef]
  36. Hossain, M.F.; Ratnayake, R.R.; Meerajini, K.; Wasantha Kumara, K.L. Antioxidant properties in some selected cyanobacteria isolated from fresh water bodies of Sri Lanka. Food Sci. Nutr. 2016, 4, 753–758. [Google Scholar] [CrossRef] [Green Version]
  37. Pumas, C.; Vacharapiyasophon, P.; Peerapornpisal, Y.; Leelapornpisid, P.; Boonchum, W.; Ishii, M.; Khanongnuch, C. Thermostablility of phycobiliproteins and antioxidant activity from four thermotolerant cyanobacteria. Phycol. Res. 2011, 59, 166–174. [Google Scholar] [CrossRef]
  38. Pez Jaeschke, D.; Rocha Teixeira, I.; Damasceno Ferreira Marczak, L.; Domeneghini Mercali, G. Phycocyanin from Spirulina: A review of extraction methods and stability. Food Res. Int. 2021, 143, 110314. [Google Scholar] [CrossRef]
  39. Hemlata; Fatma, T. Screening of cyanobacteria for phycobiliproteins and effect of different environmental stress on its yield. Bull. Environ. Contam. Toxicol. 2009, 83, 509–515. [Google Scholar] [CrossRef] [PubMed]
  40. Eriksen, N.T. Production of phycocyanin—A pigment with applications in biology, biotechnology, foods and medicine. Appl. Microbiol. Biotechnol. 2008, 80, 1–14. [Google Scholar] [CrossRef] [PubMed]
  41. Freitas-Rodriguez, S.; Folgueras, A.R.; Lopez-Otin, C. The role of matrix metalloproteinases in aging: Tissue remodeling and beyond. Biochim. Biophys. Acta Mol. Cell Res. 2017, 1864, 2015–2025. [Google Scholar] [CrossRef] [PubMed]
  42. Del Bino, S.; Bernerd, F. Variations in skin colour and the biological consequences of ultraviolet radiation exposure. Br. J. Derm. 2013, 169, 33–40. [Google Scholar] [CrossRef]
  43. Pagels, F.; Almeida, C.; Vasconcelos, V.; Guedes, A.C. Cosmetic Potential of Pigments Extracts from the Marine Cyanobacterium Cyanobium sp. Mar. Drugs 2022, 20, 481. [Google Scholar] [CrossRef]
  44. Ramos, V.; Morais, J.; Castelo-Branco, R.; Pinheiro, A.; Martins, J.; Regueiras, A.; Pereira, A.L.; Lopes, V.R.; Frazao, B.; Gomes, D.; et al. Cyanobacterial diversity held in microbial biological resource centers as a biotechnological asset: The case study of the newly established LEGE culture collection. J. Appl. Phycol. 2018, 30, 1437–1451. [Google Scholar] [CrossRef] [Green Version]
  45. Ferreira, L.; Morais, J.; Preto, M.; Silva, R.; Urbatzka, R.; Vasconcelos, V.; Reis, M. Uncovering the Bioactive Potential of a Cyanobacterial Natural Products Library Aided by Untargeted Metabolomics. Mar. Drugs 2021, 19, 633. [Google Scholar] [CrossRef]
  46. Kotai, J. Instructions for Preparation of Modified Nutrient Solution Z8 for Algae; Norwegian Institute for Water Research: Oslo, Norway, 1972; Volume 15, pp. 155–164. [Google Scholar]
  47. Fernandes, F.; Barbosa, M.; Oliveira, A.P.; Azevedo, I.C.; Sousa-Pinto, I.; Valentão, P.; Andrade, P.B. The pigments of kelps (Ochrophyta) as part of the flexible response to highly variable marine environments. J. Appl. Phycol. 2016, 28, 3689–3696. [Google Scholar] [CrossRef]
  48. Barroso, M.F.; Ramalhosa, M.J.; Alves, R.C.; Dias, A.; Soares, C.M.D.; Oliva-Teles, M.T.; Delerue-Matos, C. Total antioxidant capacity of plant infusions: Assessment using electrochemical DNA-based biosensor and spectrophotometric methods. Food Control 2016, 68, 153–161. [Google Scholar] [CrossRef]
  49. Barbosa, M.; Fernandes, F.; Carlos, M.J.; Valentão, P.; Andrade, P.B. Adding value to marine invaders by exploring the potential of Sargassum muticum (Yendo) Fensholt phlorotannin extract on targets underlying metabolic changes in diabetes. Algal Res. 2021, 59, 102455. [Google Scholar] [CrossRef]
  50. Ferreres, F.; Lopes, G.; Gil-Izquierdo, A.; Andrade, P.B.; Sousa, C.; Mouga, T.; Valentao, P. Phlorotannin extracts from fucales characterized by HPLC-DAD-ESI-MSn: Approaches to hyaluronidase inhibitory capacity and antioxidant properties. Mar. Drugs 2012, 10, 2766–2781. [Google Scholar] [PubMed] [Green Version]
  51. Mota, F.A.R.; Pereira, S.A.P.; Araujo, A.; Saraiva, M. Evaluation of Ionic Liquids and Ionic Liquids Active Pharmaceutical Ingredients Inhibition in Elastase Enzyme Activity. Molecules 2021, 26, 200. [Google Scholar] [CrossRef] [PubMed]
  52. Andrade, J.M.; Dominguez-Martin, E.M.; Nicolai, M.; Faustino, C.; Rodrigues, L.M.; Rijo, P. Screening the dermatological potential of plectranthus species components: Antioxidant and inhibitory capacities over elastase, collagenase and tyrosinase. J. Enzym. Inhib. Med. Chem. 2021, 36, 257–269. [Google Scholar] [CrossRef] [PubMed]
  53. Adhikari, A.; Devkota, H.P.; Takano, A.; Masudaà, K.; Nakaneà, T.; Basnet, P.; Skalko-Basnet, N. Screening of Nepalese crude drugs traditionally used to treat hyperpigmentation: In vitro tyrosinase inhibition. Int. J. Cosmet. Sci. 2008, 30, 353–360. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Carotenoid and chlorophyll profile of acetonic extracts of cyanobacteria strains. HPLC-PDA recorded at 450 nm. Unidentified carotenoids (1,3,8,9,11,12,15), Zeaxanthin (5), Chlorophyll-a derivative (6), Myxoxanthophyll (7), Echinenone (10), β-carotene (13), Phaeophytin-a (14), and γ-carotene (16).
Figure 1. Carotenoid and chlorophyll profile of acetonic extracts of cyanobacteria strains. HPLC-PDA recorded at 450 nm. Unidentified carotenoids (1,3,8,9,11,12,15), Zeaxanthin (5), Chlorophyll-a derivative (6), Myxoxanthophyll (7), Echinenone (10), β-carotene (13), Phaeophytin-a (14), and γ-carotene (16).
Marinedrugs 20 00761 g001
Figure 2. Superoxide anion radical (O2•−) scavenging activity of cyanobacteria acetonic (a) and aqueous (b) extracts. Values are expressed as the mean ± SD of at least three independent experiments, performed in duplicate.
Figure 2. Superoxide anion radical (O2•−) scavenging activity of cyanobacteria acetonic (a) and aqueous (b) extracts. Values are expressed as the mean ± SD of at least three independent experiments, performed in duplicate.
Marinedrugs 20 00761 g002
Table 1. Carotenoid and chlorophyll contents (μg mg−1 dry extract) in the aqueous and acetonic extracts of the cyanobacteria strains, determined by HPLC-PDA 1,2.
Table 1. Carotenoid and chlorophyll contents (μg mg−1 dry extract) in the aqueous and acetonic extracts of the cyanobacteria strains, determined by HPLC-PDA 1,2.
PeakCompoundRT (min)Cyanobium sp.
LEGE 07175
Synechococcales
cyanobacterium
LEGE 181150
Leptothoe sp.
LEGE 181156
Synechococcales
cyanobacterium
LEGE 181157
Synechococcales
cyanobacterium
LEGE 181158
Oscillatoriales
cyanobacterium
LEGE 191159
Aqueous
Extract
Acetonic
Extract
Aqueous
Extract
Acetonic
Extract
Aqueous
Extract
Acetonic
Extract
Aqueous
Extract
Acetonic
Extract
Aqueous
Extract
Acetonic
Extract
Aqueous
Extract
1Unidentified carotenoid13.35nq7.28 ± 0.03 and2.55 ± 0.04 cnd3.31 ± 0.07 bndndndndnd
2Lutein13.44ndndndndndndnd2.07 ± 0.70nd1.96 ± 0.15nd
3Unidentified carotenoid14.810.53 ± 0.0521.03 ± 0.40 a0.04 ± 0.027.75 ± 0.39 bnq8.53 ± 0.03 bndndnd0.77 ± 0.12 cnd
4Chlorophyll−a17.02ndnd14.77 ± 1.21 A32.19 ± 1.020.81 ± 0.06 Cnd0.06 ± 0.002nd9.42 ± 1.01 B31.96 ± 2.048.69 ± 0.07 B
5Zeaxanthin17.151.58 ± 0.0853.08 ± 1.48 andnd39.85 ± 2.69 b24.38 ± 0.33 cndnd
6Chlorophyll−a derivative17.98nd25.27 ± 1.17 bnd29.23 ± 0.69 a,bnd34.81 ± 1.52 a nd12.69 ± 2.04 cnq21.90 ± 3.55 bnd
7Myxoxanthophyll21.07ndnd0.29 ± 0.03 A8.22 ± 0.37 and4.07 ± 0.38 b0.01 ± 0.002 C5.41 ± 0.28 a,b0.17 ± 0.05 A,B8.43 ± 1.41 a0.16 ± 0.01 B
8Unidentified carotenoid22.18nd1.40 ± 0.18 and2.13 ± 0.07 and1.27 ± 0.02 bnd1.15 ± 0.03 bnd1.76 ± 0.41 and
9Unidentified carotenoid25.89nq1.21 ± 0.15 and0.70 ± 0.01 bnd1.37 ± 0.17 and0.26 ± 0.08 bndndnd
10Echinenone27.01nd1.17 ± 0.07ndndndndndndndndnd
11Unidentified carotenoid28.93nd1.10 ± 0.04 bndndnd2.02 ± 0.24 and1.15 ± 0.14 bnd1.00 ± 0.08 bnd
12Unidentified carotenoid29.7nq0.41 ± 0.16 bnq1.15 ± 0.07 andndnd0.26 ± 0.09 bndndnq
13β−Carotene34.320.88 ± 0.11 B19.58 ± 0.64 c1.22 ± 0.11 A25.13 ± 0.75 b,c0.05 ± 0.002 D47.89 ± 2.81 a0.10 ± 0.002 D29.30 ± 0.56 b0.54 ± 0.05 C30.57 ± 1.63 b0.68 ± 0.01 B,C
14Phaeophytin-a34.69nq5.81 ± 1.08 and2.25 ± 0.61 bnd1.81 ± 0.11 bnd5.23 ± 0.27 and6.31 ± 0.33 and
15Unidentified carotenoid35.05nq3.92 ± 0.18 cnq5.23 ± 0.64 a,bnq6.51 ± 0.24 anq3.37 ± 0.11 cnq4.53 ± 0.60 b,cnq
16γ−Carotene41.78ndnqnd35.96 ± 3.00 and33.52 ± 3.79 and32.11 ± 1.47 and26.51 ± 1.99 bnd
Total carotenoids3.00 ±≤ 0.01 A115.98 ± 0.48 c1.55 ±≤ 0.01 B123.26 ± 0.85 b0.05 ±≤ 0.01 F150.15 ± 1.40 a0.18 ±≤ 0.01 E104.71 ± 0.42 d0.71 ±≤ 0.01 D113.81 ± 0.81 c0.84 ±≤ 0.01 C
Total chlorophyllsnd25.27 ± 1.17 a,b14.77 ± 1.21 A29.23 ± 0.69 a,b0.81 ± 0.06 C34.81 ± 1.52 a nd12.69 ± 2.04 c9.42 ± 1.01 B21.90 ± 3.55 b,c8.69 ± 0.07 B
1 Values are expressed as mean ± SD of two determinations. 2 Different superscript letters in the same row denote statistical differences at p < 0.05 (ANOVA, Tukey’s HSD); uppercase, Aqueouse extracts; lowercase, Acetonic extracts. nd: Not detected. nq: Not quantified.
Table 2. Total Phenolic Content (TPC) and Total Proteins present in cyanobacterial extracts 1,2.
Table 2. Total Phenolic Content (TPC) and Total Proteins present in cyanobacterial extracts 1,2.
StrainsTPC (μg (GAE) mg−1 dry extract)Total Proteins (μg (BSA) mg−1dry extract)
Aqueous ExtractsAcetonic ExtractsAqueous ExtractsAcetonic Extracts
Cyanobium sp. LEGE 0717514.79 a,b ± 0.2023.11 a,b ± 0.69309.63 e ± 4.26167.49 b ± 4.93
Synechococcales cyanobacterium
LEGE 181150
14.49 a,b ± 0.4820.14 b,c ± 0.16695.25 b ± 10.35199.37 a ± 6.38
Leptothoe sp. LEGE 18115614.93 a,b ± 0.2727.13 a ± 0.07463.70 d ± 8.78158.67 ± 2.58
Synechococcales cyanobacterium
LEGE 181157
14.92 a,b ± 0.6617.86 c ± 0.06760.81 a ± 15.72128.84 c ± 7.12
Synechococcales cyanobacterium
LEGE 181158
15.67 a ± 0.2324.71 a,b ± 0.53579.99 c ± 12.36209.31 a ± 4.36
Oscillatoriales cyanobacterium
LEGE 181159
11.46 b ± 0.67550.59 c ± 18.14
1 Mean ± SD of three independent experiments. 2 Different superscript letters in the same column correspond to statistical differences at p < 0.05 (ANOVA, Tukey’s HSD). − not evaluated.
Table 3. Phycobiliproteins content (μg mg−1dry extract) in cyanobacteria aqueous extracts 1,2.
Table 3. Phycobiliproteins content (μg mg−1dry extract) in cyanobacteria aqueous extracts 1,2.
StrainsPhycobiliproteins (μg mg−1 dry aqueous extract)
PhycocyaninAllophycocyaninPhycoerythrin
Cyanobium sp. LEGE 0717518.21 f ± 1.3611.26 e ± 1.208.06 e ± 1.17
Synechococcales cyanobacterium LEGE 181150222.76 a ± 0.7957.29 b ± 0.1717.31 d ± 0.11
Leptothoe sp. LEGE 18115676.10 e ± 0.1337.05 d ± 0.28159.05 b ± 0.14
Synechococcales cyanobacterium LEGE 181157117.94 d ± 0.1244.57 c ± 0.28275.04 a ± 0.30
Synechococcales cyanobacterium LEGE 181158194.43 c ± 0.3944.52 c ± 0.3417.42 d ± 0.22
Oscillatoriales cyanobacterium LEGE 181159201.15 b ± 0.7865.90 a ± 0.6726.33 c ± 0.16
1 Values are expressed as the mean ± SD of three independent experiments. 2 Different superscript letters in the same column correspond to statistical differences at p < 0.05.
Table 4. Inhibitory concentration (IC) values (μg mL−1) of cyanobacteria aqueous and acetonic extracts against superoxide anion radical (O2•−) 1,2.
Table 4. Inhibitory concentration (IC) values (μg mL−1) of cyanobacteria aqueous and acetonic extracts against superoxide anion radical (O2•−) 1,2.
StrainsO2•− (μg mL−1)
Aqueous ExtractsAcetonic Extracts
IC25IC50IC25IC50
Cyanobium sp. LEGE 07175248.31 c ± 1.97816.22 c ± 11.48921.46 b ± 77.091549.10 b ± 65.28
Synechococcales cyanobacterium LEGE 18115025.48 a,b ± 9.46112.18 a ± 12.46538.01 a ± 67.00943.45 a ± 45.48
Leptothoe sp. LEGE 18115641.10 a,b ± 5.24nd647.24 a ± 8.951097.05 a ± 2.41
Synechococcales cyanobacterium LEGE 18115725.48 a,b ± 6.8163.24 a ± 24.67467.26 a ± 41.66847.65 a ± 30.70
Synechococcales cyanobacterium LEGE 18115851.22 b ± 24.20404.59 b ± 14.301032.15 b ± 139.101463.69 b ± 271.87
Oscillatoriales cyanobacterium LEGE 18115912.27 a ± 0.70332.40 b ± 77.41
1 Mean ± SD of at least three independent experiments, performed in duplicate. 2 Different superscript letters in the same column correspond to statistical differences at p < 0.05 (ANOVA; Tukey’s HSD). nd: not determined. −: not evaluated.
Table 5. Inhibitory concentration (IC) values (μg mL−1) of cyanobacteria aqueous and acetonic extracts obtained for hyaluronidase, elastase, and tyrosinase 1,2.
Table 5. Inhibitory concentration (IC) values (μg mL−1) of cyanobacteria aqueous and acetonic extracts obtained for hyaluronidase, elastase, and tyrosinase 1,2.
StrainsHyaluronidase (μg mL−1)Elastase (μg mL−1)Tyrosinase (μg mL−1)
Aqueous ExtractsAcetonic ExtractsAcetonic ExtractsAcetonic Extracts
IC25IC50IC25IC50IC25IC50IC25IC50
Cyanobium sp.
LEGE 07175
488.39 a,b ± 97.20894.59 c ± 78.14796.94 a ± 284.55ndndnd795.57 b ± 198.79nd
Synechococcales cyanobacterium
LEGE 181150
257.05 a,b ± 1.39483.86 a ± 86.71595.11 a ± 4.77726.29 a ± 16.56ndndndnd
Leptothoe sp.
LEGE 181156
800.00 c ± 152.73ndndnd378.26 b ± 24.50nd133.47 a ± 35.40465.92 a ± 37.59
Synechococcales cyanobacterium
LEGE 181157
188.89 a ± 86.14645.06 a,b ± 118.73613.47 a ± 82.241859.83 a ± 122.0851.43 a ± 20.02380.50 ± 19.72381.33 a ± 14.378849.48 b ± 75.815
Synechococcales cyanobacterium
LEGE 181158
397.72 a,b ± 70.00624.51 a,b ± 19.84442.63 a ± 36.54738.88 a ± 83.79233.47 b ± 89.26ndndnd
Oscillatoriales cyanobacterium
LEGE 181159
518.69 b,c ± 15.68801.30 b,c ± 116.04
1 Mean ± SD of at least three independent experiments, performed in duplicate. 2 Different superscript letters in the same column correspond to statistical differences at p < 0.05 (ANOVA; Tukey’s HSD). nd: not determined. − not evaluated.
Table 6. Percentage (%) of inhibition of collagenase displayed by cyanobacteria aqueous and acetonic extracts 1,2.
Table 6. Percentage (%) of inhibition of collagenase displayed by cyanobacteria aqueous and acetonic extracts 1,2.
Strains% Collagenase Inhibition
Aqueous ExtractsAcetonic Extracts
0.75 mg mL−11 mg mL−10.75 mg mL−11 mg mL−1
Cyanobium sp. LEGE 07175nd8.91 b ± 2.132.88 a ± 1.70nd
Synechococcales cyanobacterium LEGE 181150ndnd9.81 b ± 2.2844.40 a ± 3.87
Leptothoe sp. LEGE 181156ndnd36.61 a ± 2.7236.74 a,b ± 7.82
Synechococcales cyanobacterium LEGE 181157ndndndnd
Synechococcales cyanobacterium LEGE 181158nd25.97 a ± 6.227.30 b ± 1.5824.82 b ± 4.01
Oscillatoriales cyanobacterium LEGE 181159ndnd
1 Mean ± SD of at least three independent experiments, performed in duplicate. 2 Different superscript letters in the same column correspond to statistical differences at p < 0.05 (unpaired t-test; ANOVA; Tukey’s HSD). nd: not determined. − not evaluated.
Table 7. Yield (%, w/w) obtained from sequential acetonic and aqueous extractions 1.
Table 7. Yield (%, w/w) obtained from sequential acetonic and aqueous extractions 1.
StrainsSolvents
AcetoneWater
Cyanobium sp. LEGE 071751.2 ± 0.317.2 ± 1.4
Synechococcales cyanobacterium LEGE 1811501.4 ± 0.439.0 ± 5.2
Leptothoe sp. LEGE 1811561.9 ± 0.626.6 ± 5.3
Synechococcales cyanobacterium LEGE 1811571.6 ± 0.631.7 ± 8.4
Synechococcales cyanobacterium LEGE 1811581.5 ± 0.323.4 ± 5.6
Oscillatoriales cyanobacterium LEGE 18115938.9 ± 1.0
1 Values are expressed as Mean ± SD of at least four extractions. − not evaluated.
Table 8. Calibration curves of authentic standards used for quantification of different carotenoids and chlorophylls.
Table 8. Calibration curves of authentic standards used for quantification of different carotenoids and chlorophylls.
StandardsCalibration Curver2
Luteiny = 31,188,975x + 81,3680.9987
Chlorophyll-a y =5,647,422x + 14,8380.9989
Zeaxanthiny = 40,108,171x + 97,8100.9994
Cantaxanthiny = 39,997,059x + 197,6550.9992
Myxoxantophylly = 30,518,380x + 59760.9993
Echinenoney = 74,770,292x + 126,8780.9997
β-Caroteney = 31,852,521x + 16,1270.9999
γ-Caroteney = 452,252x + 17,5740.9913
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Morone, J.; Lopes, G.; Morais, J.; Neves, J.; Vasconcelos, V.; Martins, R. Cosmetic Application of Cyanobacteria Extracts with a Sustainable Vision to Skincare: Role in the Antioxidant and Antiaging Process. Mar. Drugs 2022, 20, 761. https://doi.org/10.3390/md20120761

AMA Style

Morone J, Lopes G, Morais J, Neves J, Vasconcelos V, Martins R. Cosmetic Application of Cyanobacteria Extracts with a Sustainable Vision to Skincare: Role in the Antioxidant and Antiaging Process. Marine Drugs. 2022; 20(12):761. https://doi.org/10.3390/md20120761

Chicago/Turabian Style

Morone, Janaína, Graciliana Lopes, João Morais, Jorge Neves, Vítor Vasconcelos, and Rosário Martins. 2022. "Cosmetic Application of Cyanobacteria Extracts with a Sustainable Vision to Skincare: Role in the Antioxidant and Antiaging Process" Marine Drugs 20, no. 12: 761. https://doi.org/10.3390/md20120761

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop